Medical device correction: FreeStyle Libre 3 (Abbott – December)

Dec. 2025Pharmacy Updates

Abbott has announced a medical device correction for certain FreeStyle Libre 3 sensors. These sensors monitor blood glucose levels as part of the FreeStyle Libre system, which includes a sensor, reader, and app. The correction applies only to the sensor. No other Libre products or Abbott biowearables are affected.

The sensors are being corrected because some may give incorrect low glucose readings. Individuals with diabetes who get false low readings may make unsafe treatment decisions, such as such as excessive carbohydrate intake or skipping insulin doses. This can pose serious health risks, including injury or death.

The groups below are part of the correction.

  • FreeStyle Libre 3 Sensor
    • Model numbers: 72081-01, 72080-01
    • Unique device identifiers (UDI-DIs): 00357599818005 and 00357599819002
  • FreeStyle Libre 3 Plus Sensor
    • Model numbers: 78768-01, 78769-01
    • UDI-DIs: 00357599844011 and 00357599843014

If a patient’s device’s model number or UDI-DI is listed above, they should visit FreeStyleCheck.com and enter their sensor serial number to learn if their device is affected by the correction. The website explains how to find the serial number.

The FDA recommends that patients with affected sensors stop using them immediately and throw them away. They should then enter their contact information on the website so Abbott can send them a replacement sensor at no cost.

Abbott suggests that those with signs of low glucose or who think their glucose reading is wrong use any glucometer to do a fingerstick test. This includes the built-in blood glucose meter in the FreeStyle Libre 3 reader.

As of Nov. 14, Abbott had reported 736 serious injuries and 7 deaths associated with this issue. The FDA is reviewing this potentially high-risk device issue and will keep the public informed as new information becomes available.

To learn more about this recall, your patients can take one or more of the steps below.

  • Talk to your or their pharmacist.
  • Call Abbott at 1-833-815-4273. Help is available seven days a week from 8 a.m. to 8 p.m. ET.
  • Visit the FDA website.

Recent Announcements

Voluntary nationwide recall: True Metrix (Trividia – May)

Trividia Health is recalling all True Metrix Blood Glucose Systems for an issue with the software design of the E-5 Error Code and instructions for the user in the “Messages” section of the Owner’s Booklet/System instructions for use and online labeling and help guides.
May 2026Pharmacy Updates

Community Care Behavioral Health is excited to announce this free upcoming web-based training opportunity:

A growing body of U.S. and international research demonstrates that the rapid legalization and commercialization of gambling—including online casinos and mobile sports betting platforms—are associated with significant and escalating gambling related harm. Although Pennsylvania specific prevalence data remain limited, available evidence is increasingly concerning, with gambling disorder linked to alarmingly high rates of suicide, psychiatric comorbidity, and social and financial harm. Drawing on lessons from the tobacco and opioid crises, this presentation will examine how delayed recognition and regulation can amplify population level harm, underscoring the need for earlier screening, prevention, and policy engagement. Participants will gain practical guidance on identifying patients at elevated risk, implementing evidence informed screening and diagnostic strategies, and applying current treatment approaches across the lifespan.
May 2026Education/Webinars

Bridging Smiles and Systems: Collaborative Care for Children with Chronic Conditions

Please join us for a live, CME-accredited and CEU-accredited webinar on May 13 from noon to 1p.m., that will explore the critical connection between oral health and pediatric chronic conditions such as diabetes, asthma, congenital heart disease, and ADHD.
Apr. 2026Education/Webinars